Day One Biopharmaceuticals, Inc.
DAWN
$6.54
-$0.45-6.44%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/7/2025
-
GuruFocus
5/7/2025
-
GuruFocus
5/7/2025
-
SeekingAlpha
5/7/2025
-
Seeking Alpha: Transcripts
5/6/2025
-
TipRanks Financial Blog
5/6/2025
-
Zacks Investment Research
5/6/2025
-
SeekingAlpha
5/6/2025
-
GuruFocus
5/6/2025
-
The Fly
5/6/2025
-
Globe Newswire
5/6/2025
-
MarketBeat
5/6/2025
-
Ticker Report
5/5/2025
-
GuruFocus
5/4/2025
-
MarketBeat
5/4/2025
-
MarketBeat
5/3/2025
-
MarketBeat
5/2/2025
-
Ticker Report
5/1/2025
-
MarketBeat
4/28/2025
-
MarketBeat
4/26/2025
-
MarketBeat
4/23/2025
-
MarketBeat
4/23/2025
-
Tickeron - Stocks
4/23/2025
-
MarketBeat
4/22/2025
-
Globe Newswire
4/21/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 484 0899
Address
1800 Sierra Point Parkway
Brisbane, CA 94005
Brisbane, CA 94005
Country
Year Founded
Business Description
Sector
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company’s lead...
more